Copyright
©2013 Baishideng Publishing Group Co.
World J Cardiol. Jul 26, 2013; 5(7): 247-253
Published online Jul 26, 2013. doi: 10.4330/wjc.v5.i7.247
Published online Jul 26, 2013. doi: 10.4330/wjc.v5.i7.247
Table 1 Baseline characteristics of study population: Clinical, laboratory and imaging data n (%)
Variables | n = 86 |
Male gender | 67 (77.9) |
Age (yr) | 55.87 ± 11.85 |
Background diseases | |
Stage-1 (malignant) hypertension | 14 (16.3) |
Stage-2 hypertension | 65 (75.6) |
Diabetes mellitus | 34 (39.5) |
Smoking | 61 (70.9) |
Clinical features of left ventricular dysfunction | 23 (26.7) |
Left ventricular hypertrophy | 29 (33.7) |
Coronary artery disease | 72 (83.7) |
Blood pressure | |
Systolic (mmHg) | 170.15 ± 20.10 |
Diastolic (mmHg) | 98.38 ± 10.55 |
Antihypertensive drugs (n) | 3.07 ± 0.69 |
Indication criteria | |
Hypertension resistant to standard medication | 71 (82.6) |
Renal bruit | 53 (61.6) |
Serum creatinine (mg/dL) | 20 (23.3) |
Stenosis | |
Bilateral | 23 (26.7) |
Coronary angiography | |
Single vessel disease | 25 (29.1) |
Double vessel disease | 14 (16.3) |
Triple vessel disease | 28 (32.6) |
Normal vessel | 19 (22.1) |
- Citation: Prajapati JS, Jain SR, Joshi H, Shah S, Sharma K, Sahoo S, Virparia K, Thakkar A. Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting. World J Cardiol 2013; 5(7): 247-253
- URL: https://www.wjgnet.com/1949-8462/full/v5/i7/247.htm
- DOI: https://dx.doi.org/10.4330/wjc.v5.i7.247